|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBSCO_on1317842424 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
220518s2021 au o 000 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d EBLCP
|d N$T
|d OCLCF
|d OCLCQ
|d SFB
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 9789201032218
|q (electronic bk.)
|
| 020 |
|
|
|a 9201032218
|q (electronic bk.)
|
| 035 |
|
|
|a (OCoLC)1317842424
|
| 050 |
|
4 |
|a RS431.R34
|
| 082 |
0 |
4 |
|a 616.07575
|2 23
|
| 049 |
|
|
|a UAMI
|
| 110 |
2 |
|
|a International Atomic Energy Agency,
|e issuing body.
|
| 245 |
1 |
0 |
|a Alternative radionuclide production with a cyclotron.
|
| 264 |
|
1 |
|a Vienna :
|b International Atomic Energy Agency,
|c 2021.
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
0 |
|
|a IAEA radioisotopes and radiopharmaceuticals reports ;
|v no. 4
|
| 505 |
0 |
|
|a Intro -- 1. INTRODUCTION -- 1.1. Background -- 1.2. Objective -- 1.3. Scope -- 1.4. Structure -- 2. CYCLOTRON PARAMETERS -- 2.1. General considerations -- 2.2. Positive versus negative ion cyclotrons -- 2.3. Cyclotron facilities -- 2.3.1. Facility considerations -- 2.3.2. Nuclear reactions -- 2.4. Cyclotron database -- 3. CYCLOTRON TARGETRY -- 3.1. General considerations -- 3.2. Target types -- 4. CYCLOTRON BASED ALTERNATIVE RADIONUCLIDE PRODUCTION -- 4.1. Overview -- 4.2. Actinium-225 -- 4.2.1. Production parameters -- 4.2.2. Targetry and separation chemistry -- 4.3. Antimony
|
| 505 |
8 |
|
|a 4.3.1. Production parameters -- 4.3.2. Targetry and separation chemistry -- 4.4. Arsenic -- 4.4.1. Production parameters -- 4.4.2. Targetry, irradiation parameters and separation chemistry -- 4.5. Astatine-211 -- 4.5.1. Production parameters -- 4.5.2. Targetry and separation chemistry -- 4.6. Bismuth-213 -- 4.6.1. Production parameters -- 4.6.2. Targetry and separation chemistry -- 4.7. Bromine -- 4.7.1. Production parameters -- 4.7.2. Targetry and separation chemistry -- 4.8. Calcium-47 -- 4.8.1. Production parameters -- 4.8.2. Targetry and separation chemistry -- 4.9. Cobalt
|
| 505 |
8 |
|
|a 4.9.1. Production parameters -- 4.9.2. Targetry and separation chemistry -- 4.10. Copper -- 4.10.1. Production parameters -- 4.10.2. Targetry and separation chemistry -- 4.11. Erbium-165 -- 4.11.1. Production parameters -- 4.11.2. Targetry, irradiation parameters and separation chemistry -- 4.12. Gallium -- 4.12.1. Production parameters -- 4.12.2. Targetry and separation chemistry -- 4.13. Germanium-68 -- 4.13.1. Production parameters -- 4.13.2. Targetry and separation chemistry -- 4.14. Indium -- 4.14.1. Production parameters -- 4.14.2. Targetry and separation chemistry -- 4.15. Iodine
|
| 505 |
8 |
|
|a 4.15.1. Production parameters -- 4.15.2. Targetry and separation chemistry -- 4.16. Iron-52 -- 4.16.1. Production parameters -- 4.16.2. Targetry and separation chemistry -- 4.17. Manganese-52g -- 4.17.1. Production parameters -- 4.17.2. Targetry and separation chemistry -- 4.18. Molybdenum-99 -- 4.18.1. Production parameters -- 4.18.2. Targetry and separation chemistry -- 4.19. Niobium-90g -- 4.19.1. Production parameters -- 4.19.2. Targetry and separation chemistry -- 4.20. Paladium-103 -- 4.20.1. Production parameters -- 4.20.2. Targetry and separation chemistry -- 4.21. Platinum-191
|
| 505 |
8 |
|
|a 4.21.1. Production parameters -- 4.21.2. Targetry and separation chemistry -- 4.22. Rhenium-186g -- 4.22.1. Production parameters -- 4.22.2. Targetry and separation chemistry -- 4.23. Scandium -- 4.23.1. Production parameters -- 4.23.2. Targetry and separation chemistry -- 4.24. Strontium-82 -- 4.24.1. Production parameters -- 4.24.2. Targetry and separation chemistry -- 4.25. Technetium -- 4.25.1. Production parameters -- 4.25.2. Targetry and separation chemistry -- 4.26. Terbium-149 -- 4.26.1. Production parameters -- 4.26.2. Targetry, irradiation parameters and separation chemistry
|
| 588 |
0 |
|
|a Vendor-supplied metadata.
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Radioisotopes.
|
| 650 |
|
0 |
|a Cyclotrons.
|
| 650 |
|
0 |
|a Radiopharmaceuticals.
|
| 650 |
|
0 |
|a Nuclear medicine.
|
| 650 |
|
2 |
|a Radioisotopes
|
| 650 |
|
2 |
|a Radiopharmaceuticals
|
| 650 |
|
2 |
|a Nuclear Medicine
|
| 650 |
|
6 |
|a Isotopes radioactifs.
|
| 650 |
|
6 |
|a Cyclotrons.
|
| 650 |
|
6 |
|a Radiopharmaceutiques.
|
| 650 |
|
6 |
|a Médecine nucléaire.
|
| 650 |
|
7 |
|a cyclotrons.
|2 aat
|
| 650 |
|
7 |
|a Cyclotrons
|2 fast
|
| 650 |
|
7 |
|a Nuclear medicine
|2 fast
|
| 650 |
|
7 |
|a Radioisotopes
|2 fast
|
| 650 |
|
7 |
|a Radiopharmaceuticals
|2 fast
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3282327
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL6986021
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 3282327
|
| 994 |
|
|
|a 92
|b IZTAP
|
